Litcius/Paper detail

Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)

Elizabeth M. Anderson, Caroline Diorio, Eileen C. Goodwin, Kevin O. McNerney, Madison E. Weirick, Sigrid Gouma, Marcus J. Bolton, Claudia P. Arevalo, Julie Chase, Philip Hicks, Tomaz B. Manzoni, Amy E. Baxter, Kurt P. Andrea, Chakkapong Burudpakdee, Jessica H. Lee, Laura A. Vella, Sarah E. Henrickson, Rebecca M. Harris, E. John Wherry, Paul Bates, Hamid Bassiri, Edward M. Behrens, David T. Teachey, Scott E. Hensley

2020Journal of the Pediatric Infectious Diseases Society63 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.

Topics & Concepts

MedicineCoronavirusCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyImmunologySevere acute respiratory syndromeSevere acute respiratory syndrome coronavirusRespiratory system2019-20 coronavirus outbreakDiseaseSeverity of illnessVirologyInfectious disease (medical specialty)Internal medicineOutbreakKawasaki Disease and Coronary ComplicationsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19) | Litcius